Patent ID: 7763607
Filing Date: 2010-07-27
Classification: A61K,Y10S

Abstract:
1. A pharmaceutical composition comprising therapeutically effective quantities of: a) a K ATP channel modulator, which exhibits an IC 50 value [μmol] of less than about 50 when binding to SURy subunits, wherein y is 1, 2A, or 2B; and b) a CB x modulator, which exhibits an IC 50 value [μmol] greater than about 50 when binding to the CB 1 receptor or CB 2 receptor; wherein the CB x modulator is selected from the group consisting of: CB 1 agonists, CB 2 agonists, CB 2 antagonists, CB 2 inverse agonists, compounds having both CB 1 agonist and CB 2 agonist properties, and mixtures thereof: wherein the K wherein the CB wherein the CB wherein the CB wherein the CB wherein the compounds having both CB